Prilenia enrolls first ALS patient in their Phase II / III study
Home
news
Prilenia enrolls first ALS patient in their Phase II / III study
Prilenia enrollsĀ first ALS patient in their Phase II / III study
Emulate unveils brain chip to enhance neuroinflammatory disease research and drug discovery which will support drug development for ALS
Previous
ROBERT BROWN
Scientific Advisory Board
CLOSE